Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages

12 Jul 2016Junko Tsuboki, Yukio Fujiwara, Hasita Horlad, Daisuke Shiraishi, Toshihiro Nohara, Shingo Tayama, Takeshi Motohara, Yoichi Saito, Tsuyoshi Ikeda, Kiyomi Takaishi, Hironori Tashiro, Yukihiro Yonemoto, Hidetaka Katabuchi, Motohiro Takeya & Yoshihiro Komohara

We found that ONA reduced the extent of ovarian cancer cell proliferation induced by co-culture with human macrophages. In addition, we also found that ONA directly suppressed cancer cell proliferation. A combinatorial effect with ONA and anti-cancer drugs was also observed. The activation of signal transducer and activator of transcription 3 (STAT3), which is involved in cell proliferation and chemo-resistance, was significantly abrogated by ONA in ovarian cancer cells. Furthermore, the administration of ONA suppressed cancer progression and prolonged the survival time in a murine ovarian cancer model under single and combined treatment conditions. Thus, ONA is considered useful for the additional treatment of patients with ovarian cancer owing to its suppression of the protumour activation of TAMs and direct cytotoxicity against cancer cells.

Medical Discussion
1 effect

Reported Outcomes

DeterminantsOutcomeDetails

Red Onions Nutrition risk & protective factor
Minor Protective Factor Red Onions
Nutrition

Ovary cancer Reproductive outcome
Minor decreased risk of Ovary cancer
Reproductive system

Low evidence
-3.0%